Final publishable report from 18NRM02 PRISM-eBT

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00177016%3A_____%2F23%3AN0000079" target="_blank" >RIV/00177016:_____/23:N0000079 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Final publishable report from 18NRM02 PRISM-eBT

Popis výsledku v původním jazyce

Electronic brachytherapy (eBT) is a cost-effective radiotherapeutic modality for the treatment of skin lesions, intraoperative partial breast irradiation, intracavitary and interstitial sites, brain tumours and kypho- Intraoperative Radiotherapy (IORT). While it offers potential for an extensive utilisation, this is unlikely to be achieved whilst eBT systems rely on individual calibration procedures. In most cases these systems are not directly traceable to NMIs and rely on indirect calibration methods with uncertainties larger than clinically acceptable. This project delivered a harmonised, simplified and traceable dosimetry for eBT, detectors and measurement devices for the determination of 3D dose distributions in water, to ensure that these systems can achieve their full clinical potential. During the project several primary realizations were established for both intercavitary and superficial treatment. (obj 1 &2). Standardized traceable calibration process for 3D detectors were established (obj 3) to provide traceable dosimetry for 3D dose distribution measurements (obj.4). Contribution to standard developing organizations were performed.

Název v anglickém jazyce

Final publishable report from 18NRM02 PRISM-eBT

Popis výsledku anglicky

Electronic brachytherapy (eBT) is a cost-effective radiotherapeutic modality for the treatment of skin lesions, intraoperative partial breast irradiation, intracavitary and interstitial sites, brain tumours and kypho- Intraoperative Radiotherapy (IORT). While it offers potential for an extensive utilisation, this is unlikely to be achieved whilst eBT systems rely on individual calibration procedures. In most cases these systems are not directly traceable to NMIs and rely on indirect calibration methods with uncertainties larger than clinically acceptable. This project delivered a harmonised, simplified and traceable dosimetry for eBT, detectors and measurement devices for the determination of 3D dose distributions in water, to ensure that these systems can achieve their full clinical potential. During the project several primary realizations were established for both intercavitary and superficial treatment. (obj 1 &2). Standardized traceable calibration process for 3D detectors were established (obj 3) to provide traceable dosimetry for 3D dose distribution measurements (obj.4). Contribution to standard developing organizations were performed.

Druh

V_souhrn - Souhrnná výzkumná zpráva

CEP obor

—

OECD FORD obor

10304 - Nuclear physics

Projekt

<a href="/cs/project/8B19003" target="_blank" >8B19003: Primary standards and traceable measurement methods for X-ray emitting electronic brachytherapy devices</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Počet stran výsledku

22

Místo vydání

PTB Branschweig, Německo

Název nakladatele resp. objednatele

EURAMET

Verze

—